FDA Device recall Z-1879-2017
Pressure Injectable Arrowg+ard Blue Plus Multi-Lumen Central Venous Catheterization Kit
- FDA Device
- Class II
- terminated
- Published 2017-05-03
On 2017-05-03 the FDA classified a Class II recall of Pressure Injectable Arrowg+ard Blue Plus Multi-Lumen Central Venous Catheterization Kit by Arrow International, citing arrow International is recalling due to possible voids in the catheter hub, which could lead to an interlumen crossover.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1879-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-03-17 |
| Published | 2017-05-03 |
| Last updated | 2026-09-13 11:54 UTC |
| Company | Arrow International |
| Distribution | IL, NJ, PA |
Product
Pressure Injectable Arrowg+ard Blue Plus Multi-Lumen Central Venous Catheterization Kit. Permits venous access to central circulation by way of subclavian, jugular and femoral veins. The ARROWg+ard technology is intended to provide protection against catheter-related bloodstream infections (CRBSIs). It is not intended to be used as a treatment for existing infections nor is it indicated for long-term use (>30 days). Clinical effectiveness of the ARROW g+ard Blue Plus catheter in preventing CRBSIs compared to the original ARROWg+ard Blue catheter has not been studied
Reason
Arrow International is recalling due to possible voids in the catheter hub, which could lead to an interlumen crossover.
Identifiers
| code_info | Product Codes ASK-45703-PRWJ1, ASK-45703-PUAB1, and ASK-45703-PUPM Lot # 13F16L0105, 23F16K0180 and 13F16L0199 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1879-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.